Thursday, October 3, 2013
The vast majority of dollars from the NIH's
recent Alzheimer's disease grants are for clinical research, but the institute
also made a trio of awards to academics to develop a systems biology picture of
the brain disorder. The teams hope to uncover new mechanisms and targets that
may have been overlooked because of the field's traditional focus on b-amyloid.
Osherovich, L. SciBX 6(38);
Published online Oct. 3, 2013
1. Osherovich, L. SciBX
2. Schadt, E.E. Nature
461, 218-223 (2009)
3. Chakrabarty, P. et
al. FASEB J. 24, 548-559 (2010)
AND INSTITUTIONS MENTIONED
Brigham and Women's Hospital, Boston, Mass.
Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J.
Mount Sinai Hospital, New York, N.Y.
National Institute on Aging, Bethesda, Md.
National Institutes of Health, Bethesda, Md.
Sage Bionetworks, Seattle, Wash.
Rush University Medical Center, Chicago, Ill.
University of Florida, Gainesville, Fla.